A bipartisan group of U.S. lawmakers on July 27 issued a formal inquiry on the Food and Drug Administration's (FDA) regulation of cannabidiol (CBD), a compound derived from the cannabis sativa plant. House Energy and Commerce Committee Chair Cathy McMorris ...